SCHEMBL7415732

SCHEMBL7415732

O=C(NO)C(CNS(=O)(=O)c1ccc(Cl)cc1)NS(=O)(=O)c1cc(Cl)ccc1Cl

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP7 P09237 4/20 0.56
MMP9 P14780 2/20 0.56
MMP10 P09238 1/20 0.56
RAB9A P51151 1/20 0.46
PSMB5 P28074 1/20 0.46
MEP1B Q16820 1/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
ALDH1A1 P00352 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDM4E B2RXH2 1/20 0.43
MAPK1 P28482 1/20 0.43
FLT1 P17948 1/20 0.42
FLT4 P35916 1/20 0.42
KDR P35968 1/20 0.42
MMP1 P03956 1/20 0.42
MMP2 P08253 1/20 0.42
MMP8 P22894 1/20 0.42
MMP13 P45452 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7407679 0.95 MMP7 (0.56) MMP7MMP9MMP10RAB9APSMB5
SCHEMBL7418075 0.93 MMP7 (0.55) MMP7MMP9MMP10RAB9APSMB5
SCHEMBL7417174 0.92 MMP7 (0.58) MMP7MMP9MMP10RAB9APSMB5
SCHEMBL7408585 0.91 MMP7 (0.60) MMP7MMP9MMP10RAB9APSMB5
SCHEMBL7416093 0.89 MMP7 (0.52) MMP7MMP9MMP10RAB9APSMB5
SCHEMBL7415251 0.88 MMP7 (0.70) MMP7MMP9MMP10MEP1BCA1
SCHEMBL7410656 0.87 MMP7 (0.58) MMP7MMP9MMP10RAB9APSMB5
SCHEMBL7415213 0.86 MMP7 (0.60) MMP7MMP9MMP10RAB9AALDH1A1
SCHEMBL7418006 0.84 MMP7 (0.47) MMP7MMP9MMP10RAB9APSMB5
SCHEMBL7414873 0.83 MMP7 (0.48) MMP7MMP9MMP10RAB9APSMB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed